November 10, 2025 - 21:01

From his third-floor office at Arizona State University, floor-length windows provide Sethuraman Panchanathan with a breathtaking view of the expansive Tempe campus. This picturesque setting is familiar to Panchanathan, who serves as a Professor of Technology and Innovation and previously held the position of director at the National Science Foundation.
In his return to ASU, Panchanathan is focused on making science and technology more accessible to a broader audience. He believes that fostering inclusivity in these fields is crucial for innovation and progress. By leveraging his extensive experience and leadership, Panchanathan aims to create initiatives that break down barriers and encourage participation from diverse communities.
His commitment to accessibility reflects a growing recognition of the importance of inclusivity in STEM education and careers. As he embarks on this new chapter at ASU, Panchanathan is poised to inspire the next generation of scientists and technologists, ensuring that opportunities are available to all.
September 30, 2026 - 21:59
Micron Technology Tops Lofty Fiscal Q4 Goals, Guides Above ViewsMicron Technology exceeded analyst expectations for its fiscal fourth quarter, delivering results that outperformed even the most optimistic projections on Wall Street. The memory chip maker...
September 30, 2026 - 01:50
Space Force Turns to Laser Systems to Shield Launch Sites from Drone ThreatsThe U.S. Space Force is moving forward with plans to deploy laser technology as part of a broader effort to defend its launch facilities from unauthorized drones. The initiative focuses on...
September 29, 2026 - 04:58
DIU Seeks Investors in Counter-Unmanned Systems TechnologyThe Defense Innovation Unit is looking for private investors to back companies working on counter unmanned systems technology. The effort targets firms building tools to detect, track, and disable...
September 28, 2026 - 02:02
Novo Nordisk (CPSE:NOVO B) Secures Long-Acting Injectable Technology In €1.165 Billion Nanexa Licensing AgreementNovo Nordisk has entered a global licensing agreement with Swedish drug delivery company Nanexa, valued at up to 1.165 billion euros. The deal centers on Nanexa`s PharmaShell technology, a platform...